Search words under length of 4 characters are not processed.
1625 results:
821. DZNE involved in two new research networks  
DZNE involved in two new research networks More than three million euros in funding from the state of NRW Scientists from the DZNE’s Bonn site are participating in two new research networks…  
Björn Falkenburger 822. Research areas/focus  
Areas of investigation/research focus Basic Neurobiological Research Parkinson's disease is characterized by degeneration of dopaminergic neurons and aggregates of the protein synuclein. In…  
823. Alzheimer's: Amyloid and Tau Are a Perilous Couple  
DZNE study provides new insights into pathological phenomena of Alzheimer‘s disease. Current Findings Give Backing to Anti-Amyloid Therapies Magdeburg/Germany, March 30, 2022. In the course of…  
824. Three young DZNE researchers receive Alzheimer Doctoral Scholarships from the Hans and Ilse Breuer Foundation  
Three young DZNE researchers receive Alzheimer Doctoral Scholarships from the Hans and Ilse Breuer Foundation In order to support young researchers in the field of dementia research in Germany,…  
825. DZG statement on the Russian invasion of Ukraine  
DZG statement on the Russian invasion of Ukraine We, the German Centers for Health Research (DZG), consider the Russian invasion of Ukraine an attack on elementary values of freedom, democracy and…  
826. DZNE scientist Patrick Weydt is a guest in the current "ALS Podcast" of the Charité  
DZNE scientist Patrick Weydt is a guest in the current "ALS Podcast" of the Charité DZNE researcher PD Dr. Patrick Weydt is a guest on the current "ALS Podcast" of Charité - Universitätsmedizin…  
827. Prof. Joachim Schultze as a guest on "Campus Talks" on ARD-alpha  
Prof. Joachim Schultze as a guest on "Campus Talks" on ARD-alpha Editor's tip: Prof. Joachim Schultze, Director Systems Medicine at the DZNE and Professor for Genomics and Immunoregulation at…  
828. European Partnership between Academia and Pharma to Study SCA3 Ataxia  
A European research consortium led by DZNE will be investigating the neurodegenerative disease “Spinocerebellar Ataxia Type 3” (SCA3) in collaboration with the French pharmaceutical company Servier…  
829. Long-term Benzodiazepine Use Attacks Synapses  
Long-term Benzodiazepine Use Attacks Synapses Benzodiazepines are effective and widely used drugs for treating states of anxiety and sleep disorders. While short-term treatments are considered…  
830. Alzheimer’s: Protective Immune Cells Active Decades Before Symptom Onset  
In individuals with a genetic predisposition to Alzheimer’s disease, the immune cells of the brain – the “microglia” – start exerting a protective effect up to two decades before the first symptoms…  
Search results 821 until 830 of 1625

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: